FEATURED COMPANIES
- Abbott Diagnostics
- Danaher Corporation
- Roche Diagnostics
- Siemens Healthineers
- Sysmex Corporation
- Thermo Fisher Scientific
- MORE
In Vitro Diagnostic services are done either through imaging like scanning, radiology, and ultrasound or in laboratories via pathology, IVD plays a crucial function in identifying health-related problems. In Vitro Diagnostic comes under medical device segment in France, which is utilized for disease diagnostic and medical treatment. Timely diagnosis improves the chances of positive development, thus helping in saving the costs of future treatment and improving the lives of patients. Moreover In Vitro Diagnostics also plays an important part in ongoing care program for patients. As per the report, France In Vitro Diagnostics market is expected to be around US$ 5 Billion by the end of the year 2024.
Currently, the United States dominates the In Vitro Diagnostics market followed by Europe. This particular trend is also expected to continue in the future. Growth in the number of an aging population has become one of the important drivers for the In vitro diagnostics market in France. In 1991, EU-28’s population, of persons aged 65and over was 13.9% and this figure further increased to 18.5% by the end of the year 2014. In Europe, most medical technologies are reimbursed by Public Health Authorities, generally within a third-party payer system. However, each European country has its own special nature; in a few European countries reimbursement and budgeting is decided at the regional level, whereas in some countries it is decided by the national government of that country.
This report titled “France In-Vitro Diagnostics (IVD) Market by Segments (Immunochemistry, Hematology, Infectious Immunology, Microbiology, Biochemistry, Genetic Testing), Types (Laboratory Reagents, Instruments), Companies (Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, Sysmex Corporation)” provides a complete analysis of France In-Vitro Diagnostics (IVD) market.
Laboratory reagents are the leading products in the France In-Vitro Diagnostics (IVD) Market
In this report, we have done a comprehensive analysis of France In-Vitro Diagnostics (IVD) market by products. It includes laboratory reagents and instruments market. The laboratory reagent is the leading segment in the France In-Vitro Diagnostics (IVD) market.
Immunochemistry dominates the France IVD Market
France In-Vitro Diagnostics (IVD) Market is segmented into immunochemistry, hematology, infectious immunology, microbiology, bio-chemistry, and genetic testing. Immunochemistry has the highest market in the France IVD segment.
Company Analysis
Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, Sysmex Corporation are some of the top companies in the France In-Vitro Diagnostics (IVD) Market. All the companies have been studied from three points
- Overview
- Initiatives & Recent Developments
- Sales
By Types - France In-Vitro Diagnostics (IVD) Market
- Laboratory Reagents
- Instruments
By Segments - France In-Vitro Diagnostics (IVD) Market
- Immunochemistry
- Hematology
- Infectious Immunology
- Microbiology
- Bio-chemistry
- Genetic Testing
Companies covered in this report
- Roche Diagnostics
- Abbott Diagnostics
- Siemens Healthineers
- Danaher Corporation
- Thermo Fisher Scientific
- Sysmex Corporation
FEATURED COMPANIES
- Abbott Diagnostics
- Danaher Corporation
- Roche Diagnostics
- Siemens Healthineers
- Sysmex Corporation
- Thermo Fisher Scientific
- MORE
1. Introduction
2. Research & Methodology
3. France In-Vitro Diagnostics (IVD) Market
4. Market Share - France In-Vitro Diagnostics (IVD)
4.1 By Types
4.2 By Segments
5. Types - France In-Vitro Diagnostics (IVD) Market
5.1 Laboratory Reagents
5.2 Instruments
6. Segments - France In-Vitro Diagnostics (IVD) Market
6.1 Immunochemistry
6.2 Hematology
6.3 Infectious Immunology
6.4 Microbiology
6.5 Bio-chemistry
6.6 Genetic Testing
7. Government Rules & Regulation
8. Reimbursement
8.1 Public
8.2 Private & Insurance
9. Market Dynamics
9.1 Growth Drivers
9.1.1 Increase in the Cancer Disease Population
9.1.2 Technological Advances
9.1.3 Rapidly Aging Population
9.2 Challenges
9.2.1 Cumbersome Reimbursement Procedure
10. Company Analysis
10.1 Roche Diagnostics
10.2 Abbott Diagnostics
10.3 Siemens Healthineers
10.4 Danaher Corporation
10.5 Thermo Fisher Scientific
10.6 Sysmex Corporation
Lists of Figures:
Figure-01: France IVD Market (Million US$), 2014 - 2018
Figure-02: Forecast for France IVD Market (Million US$), 2019 - 2024
Figure-03: France In-Vitro Diagnostics (IVD) Market Share (%) by Types, 2014 - 2018
Figure-04: Forecast for France IVD Market Share (%) by Segments, 2019 - 2024
Figure-05: France In-Vitro Diagnostics (IVD) Market Share (%) by Products, 2014 - 2018
Figure-06: Forecast for France IVD Market Share (%) by Products, 2019 - 2024
Figure-07: France In Vitro Diagnostic Market by Laboratory Reagents (Million US$), 2014-2018
Figure-08: France - Forecast for IVD Market by Laboratory Reagents (Million US$), 2019 - 2024
Figure-09: Alcohol Per Capita (15+) Consumption (in Liters of pure Alcohol)
Figure-10: France In Vitro Diagnostic Market by Instruments (Million US$), 2014-2018
Figure-11: France - Forecast for IVD Market by Instruments (Million US$), 2019 - 2024
Figure-12: France - In-Vitro Diagnostics Market by Immunochemistry (Million US$), 2014 - 2018
Figure-13: France - Forecast for IVD Market by Immunochemistry (Million US$), 2019 - 2024
Figure-14: France - In-Vitro Diagnostics Market by Hematology (Million US$), 2014 - 2018
Figure-15: France - Forecast for IVD Market by Hematology (Million US$), 2019 - 2024
Figure-16: France - In-Vitro Diagnostics Market by Infectious Immunology (Million US$), 2014 - 2018
Figure-17: France - Forecast for IVD Market by Infectious Immunology (Million US$), 2019 - 2024
Figure-18: France - In-Vitro Diagnostics Market by Microbiology (Million US$), 2014 - 2018
Figure-19: France - Forecast for IVD Market by Microbiology (Million US$), 2019 - 2024
Figure-20: France - In-Vitro Diagnostics Market by Bio-chemistry (Million US$), 2014 - 2018
Figure-21: France - Forecast for IVD Market by Bio-chemistry (Million US$), 2019 - 2024
Figure-22: France - In-Vitro Diagnostics Market by Genetic Testing (Million US$), 2014 - 2018
Figure-23: France - Forecast for IVD Market by Genetic Testing (Million US$), 2019 - 2024
Figure-24: Major EU Countries Cancer Rates
Figure-25: Roche Diagnostics - Global Sales (Million US$), 2014 - 2018
Figure-26: Roche Diagnostics - Global Sales Forecast (Million US$), 2019 - 2024
Figure-27: Abbott Diagnostics - Global Sales (Million US$), 2014 - 2018
Figure-28: Abbott Diagnostics - Global Sales Forecast (Million US$), 2019 - 2024
Figure-29: Siemens Healthineers - Global Diagnostics Sales (Million US$), 2015 - 2018
Figure-30: Siemens Healthineers - Global Diagnostics Sales Forecast (Million US$), 2019 - 2024
Figure-31: Danaher Corporation - Global Diagnostics Sales (Million US$), 2014 - 2018
Figure-32: Danaher Corporation - Global Diagnostics Sales Forecast (Million US$), 2019 - 2024
Figure-33: Thermo Fisher Scientific - Global Diagnostics Sales (Million US$), 2014 - 2018
Figure-34: Thermo Fisher Scientific - Global Diagnostics Sales Forecast (Million US$), 2019 - 2024
Figure-35: Sysmex Corporation - Global Diagnostics Sales (Million US$), 2014 - 2018
Figure-36: Sysmex Corporation - Global Diagnostics Sales Forecast (Million US$), 2019 - 2024
- Abbott Diagnostics
- Danaher Corporation
- Roche Diagnostics
- Siemens Healthineers
- Sysmex Corporation
- Thermo Fisher Scientific
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
